From prostate cancer to breast cancer: In conversation with Christine Roth
Oncology
At ASCO 2025, Bayer announced new data from recent clinical trials that highlight significant advancements in both prostate cancer and women’s health.
Onsite for the Congress in Chicago, web editor Nicole Raleigh sat down with Christine Roth, executive vice president of global product strategy and commercialisation at Bayer, to discuss that data and the landscape of women’s oncological health more generally.
You can find this and other conversations from ASCO 2025 here.
